Intralesional Vitamin D3 for Anogenital Warts in Human Immunodeficiency Virus Infected Individual

Zulfan,1,2 Syahla Nisaa Amalia,1 Retno Hesty Maharani,1 Rasmia Rowawi,1 Pati Aji Achdiat1 1Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran – Dr. Hasan Sadikin Hospital, Bandung, West Java, Indonesia; 2Department of Dermatology and Venereology, Faculty of Medicine Universitas Syiah Kuala – Banda Aceh, Aceh, IndonesiaCorrespondence: Pati Aji Achdiat, Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran – Dr. Hasan Sadikin Hospital, Jl. Pasteur 38, Bandung, West Java, 40161, Indonesia, Email [email protected]: Anogenital warts (AGW) is the most common sexually transmitted infection in the world caused by the Human Papillomavirus (HPV), especially types 6 and 11. Immunotherapy is one of the therapeutic modalities that can be used to treat AGW. The mechanism of Vitamin D3 on AGW is the expression of antimicrobial peptides (AMP) that directly inactivate pathogens and also enhance innate immune responses. One case of AGW type condyloma acuminata was reported in a 29-year-old male. A case of condyloma acuminata-type AGW in a 29-year-old HIV stage 1 male patient was reported. His CD4 level was 500 cells/uL, and treated with anti-retroviral (ARV). Physical examination of the perianal area revealed a skin-colored tumor with a verrucous surface. Acetowhite test and HPV type 11 polymerase chain reaction (PCR) results were positive. The patient received intralesional injection of vitamin D3 60,000 IU per lesion every two weeks four times. The lesions appeared to have shrunk by more than 50% after the fourth injection. This case report shows the potential of intralesional vitamin D3 for the treatment of AGWs in an HIV patient. However, further research is required to confirm both the efficacy and safety of intralesional vitamin D3.Keywords: anogenital warts, condyloma acuminata, human immunodeficiency virus, HIV, human papillomavirus, HPV, sexually transmitted infection, STI, vitamin D3

Publication Details

Journal
Dove Medical Press (Taylor and Francis Group)
Published
2025-11-25
Primary Topic
Cervical Cancer and HPV Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Intralesional Vitamin D3 for Anogenital Warts in Human Immunodeficiency Virus Infected Individual

Dove Medical Press (Taylor and Francis Group)
Cervical Cancer and HPV Research
article

Intralesional Vitamin D3 for Anogenital Warts in Human Immunodeficiency Virus Infected Individual

article en

Abstract

Zulfan,1,2 Syahla Nisaa Amalia,1 Retno Hesty Maharani,1 Rasmia Rowawi,1 Pati Aji Achdiat1 1Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran – Dr. Hasan Sadikin Hospital, Bandung, West Java, Indonesia; 2Department of Dermatology and Venereology, Faculty of Medicine Universitas Syiah Kuala – Banda Aceh, Aceh, IndonesiaCorrespondence: Pati Aji Achdiat, Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran – Dr. Hasan Sadikin Hospital, Jl. Pasteur 38, Bandung, West Java, 40161, Indonesia, Email [email protected]: Anogenital warts (AGW) is the most common sexually transmitted infection in the world caused by the Human Papillomavirus (HPV), especially types 6 and 11. Immunotherapy is one of the therapeutic modalities that can be used to treat AGW. The mechanism of Vitamin D3 on AGW is the expression of antimicrobial peptides (AMP) that directly inactivate pathogens and also enhance innate immune responses. One case of AGW type condyloma acuminata was reported in a 29-year-old male. A case of condyloma acuminata-type AGW in a 29-year-old HIV stage 1 male patient was reported. His CD4 level was 500 cells/uL, and treated with anti-retroviral (ARV). Physical examination of the perianal area revealed a skin-colored tumor with a verrucous surface. Acetowhite test and HPV type 11 polymerase chain reaction (PCR) results were positive. The patient received intralesional injection of vitamin D3 60,000 IU per lesion every two weeks four times. The lesions appeared to have shrunk by more than 50% after the fourth injection. This case report shows the potential of intralesional vitamin D3 for the treatment of AGWs in an HIV patient. However, further research is required to confirm both the efficacy and safety of intralesional vitamin D3.Keywords: anogenital warts, condyloma acuminata, human immunodeficiency virus, HIV, human papillomavirus, HPV, sexually transmitted infection, STI, vitamin D3

Dove Medical Press (Taylor and Francis Group)
Good health and well-being
Openalex Percentile: Top 32%
Cervical Cancer and HPV Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.